NovaBridge Biosciences American Depositary Shares
NBP
53 hedge funds and large institutions have $71.6M invested in NovaBridge Biosciences American Depositary Shares in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 12 increasing their positions, 25 reducing their positions, and 18 closing their positions.
281% more call options, than puts
Call options by funds: $118K | Put options by funds: $31K
2.25% less ownership
Funds ownership: 13.08% → 10.83% (-2.3%)
23% less funds holding
Funds holding: 69 → 53 (-16)
31% less capital invested
Capital invested by funds: $104M → $71.6M (-$32.1M)
52% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 25
89% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 18
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$1.49M |
| 2 |
Renaissance Technologies
New York
|
+$778K |
| 3 |
Barclays
London,
United Kingdom
|
+$490K |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$214K |
| 5 |
CANY
Caxton Associates (New York)
New York
|
+$179K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Cederberg Capital
London,
United Kingdom
|
-$9.26M |
| 2 |
Morgan Stanley
New York
|
-$2.31M |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$1.94M |
| 4 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
-$1.11M |
| 5 |
JP Morgan Chase
New York
|
-$1.05M |
NBP Hedge Fund Activity: Q1 2023 in Review
53 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in NovaBridge Biosciences American Depositary Shares (NBP) for Q1 2023, worth a combined $71.6M — down 31% from $104M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of NBP and 2 opened new positions — a net loss of 16 holders — while 25 trimmed existing stakes and 12 added.
The largest buyer was Millennium Management, adding an estimated $1.49M. The largest seller was Cederberg Capital, exiting entirely with an estimated $9.26M sold.
- 53 institutional investors held NovaBridge Biosciences American Depositary Shares (NBP) as of Q1 2023, down from 69 in Q4 2022.
- Funds reported $71.6M of NovaBridge Biosciences American Depositary Shares stock for Q1 2023, down 31% quarter-over-quarter.
- 2 funds opened new NovaBridge Biosciences American Depositary Shares positions in Q1 2023 and 18 closed out, a net change of -16 holders.
- The largest NovaBridge Biosciences American Depositary Shares buyer in Q1 2023 was Millennium Management, an estimated $1.49M added.
- The largest NovaBridge Biosciences American Depositary Shares seller in Q1 2023 was Cederberg Capital, an estimated $9.26M sold.
Based on aggregated 13F filings for Q1 2023.